1.30
price down icon2.99%   -0.04
after-market Dopo l'orario di chiusura: 1.31 0.01 +0.77%
loading
Precedente Chiudi:
$1.34
Aprire:
$1.34
Volume 24 ore:
938.30K
Relative Volume:
0.25
Capitalizzazione di mercato:
$57.75M
Reddito:
-
Utile/perdita netta:
$-51.50M
Rapporto P/E:
-0.325
EPS:
-4
Flusso di cassa netto:
$-47.10M
1 W Prestazione:
-2.99%
1M Prestazione:
+33.86%
6M Prestazione:
-16.13%
1 anno Prestazione:
-75.33%
Intervallo 1D:
Value
$1.28
$1.34
Intervallo di 1 settimana:
Value
$1.27
$1.48
Portata 52W:
Value
$0.79
$6.98

Outlook Therapeutics Inc Stock (OTLK) Company Profile

Name
Nome
Outlook Therapeutics Inc
Name
Telefono
(609) 619-3990
Name
Indirizzo
111 S. WOOD AVENUE, ISELIN, NJ
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-14
Name
Ultimi documenti SEC
Name
OTLK's Discussions on Twitter

Confronta OTLK con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
OTLK
Outlook Therapeutics Inc
1.30 62.63M 0 -51.50M -47.10M -4.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.63 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.00 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
575.69 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.18 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.03 34.68B 4.56B -176.77M 225.30M -1.7177

Outlook Therapeutics Inc Stock (OTLK) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-08-29 Downgrade H.C. Wainwright Buy → Neutral
2025-08-28 Downgrade Guggenheim Buy → Neutral
2024-12-02 Downgrade Chardan Capital Markets Buy → Neutral
2024-03-27 Aggiornamento BTIG Research Neutral → Buy
2024-02-15 Aggiornamento Chardan Capital Markets Neutral → Buy
2024-01-25 Aggiornamento Guggenheim Neutral → Buy
2023-12-27 Aggiornamento CapitalOne Equal Weight → Overweight
2023-08-31 Downgrade Chardan Capital Markets Buy → Neutral
2023-08-31 Downgrade H.C. Wainwright Buy → Neutral
2023-08-30 Downgrade BTIG Research Buy → Neutral
2023-08-30 Downgrade Cantor Fitzgerald Overweight → Neutral
2023-08-30 Downgrade CapitalOne Overweight → Equal Weight
2023-08-30 Downgrade Guggenheim Buy → Neutral
2023-07-13 Iniziato CapitalOne Overweight
2023-04-03 Iniziato Guggenheim Buy
2023-02-06 Iniziato Cantor Fitzgerald Overweight
2022-10-31 Iniziato BTIG Research Buy
2022-09-13 Iniziato Chardan Capital Markets Buy
2019-09-11 Iniziato Ladenburg Thalmann Buy
2019-05-16 Iniziato Oppenheimer Outperform
2019-04-22 Iniziato Ascendiant Capital Markets Buy
Mostra tutto

Outlook Therapeutics Inc Borsa (OTLK) Ultime notizie

pulisher
Oct 23, 2025

What technical models suggest about Outlook Therapeutics Inc.’s comeback - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Outlook Therapeutics Inc. stock prediction for this week2025 Price Targets & AI Forecast Swing Trade Picks - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Outlook Therapeutics Inc. (41O) stock bottoming after sell off2025 Analyst Calls & Fast Moving Market Watchlists - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Can Outlook Therapeutics Inc. stock beat analyst upgradesGlobal Markets & Real-Time Buy Zone Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Will Outlook Therapeutics Inc. (41ON) stock outperform value peersProduct Launch & Technical Buy Zone Confirmation - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How to read the order book for Outlook Therapeutics Inc.2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Is Outlook Therapeutics Inc. (41ON) stock good for long term investing2025 Market Overview & Low Risk Growth Stock Ideas - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Full technical analysis of Outlook Therapeutics Inc. stockJuly 2025 Reactions & Safe Capital Preservation Plans - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

What analyst consensus implies for Outlook Therapeutics Inc. (41O) stockWeekly Trading Summary & Pattern Based Trade Signal System - newser.com

Oct 22, 2025
pulisher
Oct 22, 2025

Outlook Therapeutics Inc. stock chart pattern explainedWatch List & Free Expert Verified Stock Movement Alerts - newser.com

Oct 22, 2025
pulisher
Oct 21, 2025

What drives Outlook Therapeutics Inc 41O stock priceAI-Driven Market Analysis & Consistent Double Returns - earlytimes.in

Oct 21, 2025
pulisher
Oct 21, 2025

What earnings margins imply for Outlook Therapeutics Inc. (41O) stockShare Buyback & Verified Trade Idea Suggestions - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Outlook Therapeutics Inc. stock continue upward trendJuly 2025 Big Picture & Weekly Market Pulse Updates - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Outlook Therapeutics Inc. (41ON) stock testing key supportJuly 2025 Intraday Action & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What is the fair value of Outlook Therapeutics Inc. stock nowMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

News impact scoring models applied to Outlook Therapeutics Inc.Portfolio Return Summary & Fast Gain Stock Trading Tips - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 17:10:41 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Outlook Therapeutics Inc. (41ON) stock attractive for growth funds2025 Market Overview & Long-Term Growth Portfolio Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What does recent volatility data suggest for Outlook Therapeutics Inc.Product Launch & Stepwise Trade Signal Implementation - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Will Outlook Therapeutics Inc. (41O) stock split increase liquidityJuly 2025 WrapUp & Smart Allocation Stock Tips - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 20, 2025

How Outlook Therapeutics Inc. stock performs in interest rate cyclesTreasury Yields & High Accuracy Trade Signal Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Aug Retail: What analyst consensus implies for Outlook Therapeutics Inc. (41O) stockJuly 2025 Short Interest & Trade Opportunity Analysis Reports - nchmf.gov.vn

Oct 20, 2025
pulisher
Oct 19, 2025

Can Outlook Therapeutics Inc. rally from current levelsWeekly Trend Summary & Community Supported Trade Ideas - newser.com

Oct 19, 2025
pulisher
Oct 18, 2025

Can Outlook Therapeutics Inc. stock attract ESG capital inflows2025 Volume Leaders & Short-Term High Return Strategies - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Investment Review: Why Outlook Therapeutics Inc. stock could be next big winnerJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - nchmf.gov.vn

Oct 18, 2025

Outlook Therapeutics Inc Azioni (OTLK) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$36.85
price up icon 0.03%
$89.31
price up icon 1.42%
$29.87
price down icon 0.17%
$104.75
price down icon 1.39%
$160.12
price down icon 0.17%
biotechnology ONC
$310.03
price down icon 1.12%
Capitalizzazione:     |  Volume (24 ore):